Fox Business - The Power to Prosper
Search Site


Buffalo Bills call on fans for help with stadium

Zor Capital Managing Director Joe Fahmy, Greywolf Execution Partners’ Mark Newton and FBN’s Liz MacDonald on the stocks that would benefit from the obesity crisis and the Buffalo Bills’ asking fans to help shovel the stadium.

Read More

  1. Prices at the pump plunge

    FNC’s James Rosen on the economic forces driving down gas prices.

  2. Fed ready to stop bond-buying program?

    CenterState Bank Executive V.P. Joe Keating, publisher Tom Lydon and SFG Alternatives CIO Larry Shover on the markets and Facebook’s third-quarter results.

  3. The race to find an Ebola vaccine

    GeoVax CEO Robert McNally on efforts to find a vaccine for Ebola.

  4. Earnings season scorecard

    Estimize director Christine Short weighs in on U.S. earnings so far.

  5. Art Nunes: Health care is a great sector to be in for long-term

    Northwest Asset Management Portfolio Manager Art Nunes on the sectors that should be on investors’ radar.

  6. Will U.S. markets continue to sell off?

    Emerald Asset Management CEO Joe Besecker and Cantor Fitzgerald U.S. Equities Head Bill Nichols on the markets, volatility and small and mid-cap stocks.

  7. Markets following October’s historic volatility?

    Altaira Senior Managing Director Ralph Acampora on the October markets.

  8. Airline stocks the best way for investors to play the Ebola crisis?

    FBN’s Charles Payne, Tea Party News Network News Director Scottie Nell Hughes, A&G Capital CIO Hilary Kramer, NewOak Capital President James Frischling, retail analyst Hitha Prabhakar and Penn Financial Group founder Matt McCall on Ebola stocks for investors’ portfolios.

  9. Will turbulence continue on Wall Street?

    Hedgeye Risk Management Founder and CEO Keith McCullough and Skybridge Capital Founbder Anthony Scaramucci discuss what to expect from and how to invest in volatile markets.

  10. Government waste: Feds spend millions getting monkeys drunk

    FBN’s Charles Payne, founder Jonathan Hoenig, Tea Party News Network News Director Scottie Nell Hughes, Divine Capital CEO Dani Hughes, retail analyst Hitha Prabhakar and Penn Financial Group founder Matt McCall on government spending.

  11. Where should investors put their money?

    Ameriprise Financial Chief Market Strategist David Joy and Lisa Shalet, Morgan Stanley’s head of investment and portfolio strategies, discuss their recommendations for investors.

  12. Chrysler makes NYSE debut

    FBN’s Liz MacDonald breaks down IPOs to watch this week.

  1. Stocks to watch: KMI, GM

    Telemus Capital Partners Chairman Gary Ran, ACE Investment Strategists Chief Trader Yu-Dee Chang and founder Mark Sebastian on the outlook for the markets.

  2. Cubist Pharmaceuticals a long-term buy?

    FBN’s Charles Payne, NewOak Capital President James Frischling, small business expert Susan Solovic, retail analyst Hitha Prabhakar and Penn Financial Group founder Matt McCall on the outlook for Cubist Pharmaceuticals.

  3. JC Penney shares fall on sales outlook concerns

    FBN’s Nicole Petallides breaks down the day in the markets.

  4. How to take advantage of the market today

    TCW U.S. Equities Group Managing Director Diane Jaffee, United Advisors Chief Market Strategist Scott Martin and Raymond James Chief Investments Strategist Jeff Saut discuss how good economic data is pushing the market up and where to invest.

  5. Can investors benefit from the midterm elections?

    Cumberland Advisors CIO David Kotok on the outlook for the markets.

  6. Opportunities for investors in Europe?

    Rosenthal Wealth Management Group President Larry Rosenthal, Harris Financial Group Managing Partner Jamie Cox and Athena Advisor Services Senior V.P. of Economic Research Dan Stecich on the outlook for the markets.

  7. Dow, S&P close at record high

    Adviser Investment Management Chief Investment Strategist Jim Lowell, A&G Capital CIO Hilary Kramer and Trading Advantage Senior Market Strategist Scott Bauer on the outlook for the markets and where the opportunities are for investors.

‹ Prev12345Next ›
Freebase CC-BY
Source: Biotechnology on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL